UMR MEMBERS DEPLOY BIOMEDICAL INNOVATION TO FIGHT COVID-19

Thousands of people in Missouri and around the country are coming down with new COVID-19 infections as the delta variant of the virus rages. In this episode of “Show Me the Science,” an infectious diseases specialist and a data scientist from Washington University School of Medicine in St. Louis talk about the need to get more people vaccinated as quickly as possible, and to enforce other public health measures while waiting for those vaccines to provide more immunity to more people.

In a wide-ranging discussion on everything from his upbringing in rural Maryland to his elevation to CEO of Becton Dickinson (BD) just as the COVID-19 pandemic was taking shape, Tom Polen walks host Scott Whitaker and listeners through the company’s work throughout the pandemic, offering leadership and management lessons, as well as insight into decision-making in times of crisis.

CBS News-KPIX’s Anne Makovec interviews Dr. Jorge Salinas with Stanford Health Care about the latest on the Delta variant and the COVID-19 vaccines.

WASHINGTON, D.C. – In the Medtech POV Podcast’s most recent episode, Hologic President and CEO Steve MacMillan led host Scott Whitaker, President and CEO of AdvaMed, through a retrospective on the company’s more than tripling of total molecular diagnostic manufacturing capacity in order to meet the demands of the COVID-19 pandemic and help save lives.

It can be stressful to be pregnant in the middle of a pandemic. It’s also stressful to deliver babies during such a time. In this episode of “Show Me the Science,” we hear about those stresses from a pair of Washington University physicians: one doctor who works in labor and delivery and another who gave birth to a baby during the pandemic.

Will we need COVID-19 booster shots and, if so, when? Where is the FDA in its approval process of the vaccines currently under emergency use authorization? What goes into this process? Why, if the current vaccines are so good, are companies still trying to make new ones? Johns Hopkins’ Dr. Anna Durbin returns to the podcast to talk with Stephanie Desmon about all things COVID-19 vaccines.

COVID-19 vaccines are being doled out across the nation, almost exclusively to adults. Pfizer’s vaccine has been authorized for ages 16 and up and Moderna’s vaccine for 18 and up. So when might younger children be vaccinated for COVID-19? And what needs to happen before then? Northwestern’s William Muller, MD, PhD, offers insight.

Masks, physical distancing and preventing students and teachers from coming to school when sick kept schools relatively safe during the recently completed school year. Researchers at Washington University School of Medicine in St. Louis believe having many teachers and some students vaccinated will make classrooms even safer when school resumes in the fall.

Three researchers break down three papers looking at what happens to patients with COVID over the longer term. Dr. Lauren Peetluck, an epidemiologist at Vanderbilt University, talks about the risks of long-term complications of COVID. Dr. Heather McKay, an epidemiologist at Johns Hopkins, talks about the risks of negative neurological and psychiatric outcomes of patients diagnosed with COVID-19. Danny Sack, an MD/PhD student at Vanderbilt, talks about post-COVID multisystem inflammatory syndrome in children.

Science—particularly biotechnology—helped change the course of COVID with the development of effective vaccines and therapeutics. However, it is also true that COVID has changed biotechnology. This episode looks at the way biotech addressed the crisis and explores how the crisis, in turn, changed the biotech industry—its reputation, its exposure to a broader audience and its willingness to adopt lessons learned from the pandemic.

Since SARS-CoV-2 was discovered in Illinois over a year ago, scientists at Northwestern University’s Feinberg School of Medicine have been tracking the evolution of the disease in the Chicago area. Ramón Lorenzo Redondo, PhD, research assistant professor of Medicine in the Division of Infectious Diseases, is part of the team leading this work. He talks about the team’s research, the new COVID-19 variants and how the vaccines on the market today stand up to them.

Harvard University researchers are taking aim at COVID-19 and other diseases with a faster, simpler, cheaper technology for generating specialized antibodies.

Researchers at Stanford Medicine have discovered a possible link to the “brain fog” that some COVID-19 patients have experienced.

Washington University in St. Louis, joins CBS News to discuss the impact this type of conflicting information could have on the mental health of Americans.

Recently, the director of the CDC officially recommended that pregnant women receive the vaccines for COVID-19. However, pregnant women are less likely than non-pregnant women to get vaccinated and are at greater risk of hospitalization and death from the disease. Emily Miller, MD, MPH, has been caring for pregnant patients at Northwestern Medicine Prentice Women’s Hospital since the onset of the pandemic. She shares results from a new study on the benefit of maternal vaccination and speaks to the history of excluding pregnant women from clinical trials.

The CDC is planning an emergency meeting next week on rare cases of heart inflammation, mostly occurring in younger men, following COVID-19 vaccination. Dr. William Schaffner, a professor a Vanderbilt University School of Medicine, joined CBS News’ Tanya Rivero to discuss this plus concerns about a decline in routine childhood vaccinations during the pandemic.

Dr. Jeff Shuren, the head of FDA’s medical device division, told a medtech audience on a podcast released this week that the agency should “re-envision” the medical device regulatory framework. Dr. Shuren recently appeared on the newly launched MedTech POV podcast hosted by AdvaMed President and CEO Scott Whitaker.

At the beginning of the pandemic, it seemed like COVID-19 didn’t really affect young people. But a recent uptick in cases and hospitalizations among younger adults could point to the transmissibility of newer variants. Dr. Emily Martin, an epidemiologist at the University of Michigan’s School of Public Health, talks with Dr. Josh Sharfstein about how the variants may be changing the risks for young people and why a virus that moves faster underscores the importance of vaccinations.

Dr. Justin Lessler, an infectious disease epidemiologist, returns to the podcast to talk to Dr. Josh Sharfstein about the Scenario Modeling Hub’s models for the fall of 2021. Researchers projected what could happen under four scenarios of vaccination rates and viral control measures. The upshot? As has been the case since the beginning, what happens next is up to us.

Families in the US are ready for rest and fun this summer after a very long year. But with unvaccinated children and changing guidance for vaccinated adults, how can families plan ahead for summer camps and travel? Guest host Dr. Colleen Barry talks with epidemiologist Dr. Keri Althoff, and Lisa David, director of an overnight camp in Pennsylvania, about COVID safety this summer and making sure that kids, who have been through so much over the last year, have a summer of fun and joy.

This is the I am BIO Uncut Series where we bring you a full interview from Monday′s podcast complete and unfiltered. In this episode, we′re joined by Richard Hatchett, CEO of the Coalition for Epidemic Preparedness Innovations or CEPI, a global vaccine procurement initiative.

President and CEO of AdvaMed Scott Whitaker catches up with Dr. Steve Hahn. Before Hahn was the head of FDA, he worked as a medical oncologist, served as a commander in the U.S. Public Health Service Commissioned Corps, managed research for the NIH, and was appointed as the Chief Medical Executive of MD Anderson Cancer Center — all before he was nominated, confirmed, and sworn in as the Commissioner of the Food and Drug Administration in late 2019. Whitaker and Hahn cover many topics, including Dr. Hahn’s time as head of FDA during the worst pandemic in a century.

COVID-19 can be a multi-system disease, impacting many organs and the entire nervous system. Igor Koralnik, MD, has been investigating the neurological complications of the disease and published the first study focused on long-term neurologic symptoms in COVID-19 “long haulers.” He explains the study and what he is seeing in the Neuro COVID-19 Clinic at Northwestern Memorial Hospital.

On May 19, Axios hosted an event discussing the unprecedented development of COVID-19 vaccines and the road ahead. Speakers included NIAID Director Dr. Anthony Fauci, Pfizer Chairman & CEO Dr. Albert Bourla and PhRMA President & CEO Stephen J. Ubl.

As the good news about the decline of COVID infections in the US continues to reverberate, the threat of the pandemic still looms globally. “Nobody is safe until everybody is safe.” Sharing life-saving vaccines around the world as quickly as possible defies a simple solution. This episode explores the recommendations and best solutions to address global distribution challenges and questions a simplistic proposal offered by some countries to the WHO: waiving Intellectual Property rights for the vaccines. Will the waiver of these protections threaten to undermine the very system that produced life-saving science in the first place?

Imagine being able to test for COVID-19 or other viruses using an app on a smartphone and getting the results within minutes. That’s the goal of a new test being developed by researchers at the University of Pennsylvania.

Are school closures helpful in preventing outbreaks of COVID-19? Epidemiologist Justin Lessler and statistician researcher Elizabeth Stuart co-authored a recent research paper looking at the risk of COVID-19 in households where a child attended in-person schooling. They talk with Stephanie Desmon about what they learned.

Jessica Wellette, instructor at the Vanderbilt School of Nursing, discusses the importance of women of pre-child bearing age to continue preventative care.

The Hidden and Here mini-series aims to use storytelling to highlight and educate clinicians on the impact that the COVID-19 pandemic has had on caregivers, non-physician essential workers and teachers who we believe have been hidden but very much here. In each episode, we will highlight their stories and a panel comprised of Sheila Lahijani, MD, Ryan Matlow, PhD, Sonoo Thadaney Israni, and Ranak Trivedi, PhD will reflect on the stories heard, discuss salient points and identify action steps that can be put in practice.

This week on AmplifyNursing we welcome the return of Dr. Alison Buttenheim. A public health researcher and behavioral epidemiologist, Dr. Buttenheim is an associate professor of nursing at UPenn School of Nursing and assistant professor of health policy at the Perelman School of Medicine. Today, we talk to Dr. Buttenheim about the current and evolving state of the coronavirus pandemic in the US and across the globe. She shares her insight into vaccine rollout, her coronavirus education project, Dear Pandemic, and her thoughts on the new normal.

PhRMA CEO Steve Ubl recently connected with Ron Busby, Sr., President and CEO of the U.S. Black Chambers, Inc. (USBC), which represents 310,000 Black-owned businesses nationwide, about how to improve vaccine confidence in communities of color.

As the official COVID-19 testing partner of USATF, tests using the BD Veritor™ Plus System will be conducted at several events throughout the Journey to Gold – Tokyo Outdoor Track & Field Series as athletes aim to qualify for the U.S. Olympic Team Trials – Track & Field.

Dr. Anne Liu is an infectious disease doctor at Stanford Health Care’s Infectious Disease Clinic.

The COVID crisis has laid bare the inequities faced by certain populations in our health care system. It has become increasingly clear that the drug development process for a whole host of diseases often leaves these same populations behind through their absence or underrepresentation in clinical trials. This episode evaluates the problem and looks for ways to improve the process so that medicines and vaccines work for everyone who takes them.

In this third special COVID-19 episode of The Brain Architects podcast, host Sally Pfitzer is joined by Dr. David Williams, the Florence Sprague Norman and Laura Smart Norman Professor of Public Health, Harvard T.H. Chan School of Public Health. Dr. Williams discusses ways in which the coronavirus pandemic is particularly affecting people of color in the U.S., and what that can mean for early childhood development. He also pinpoints the importance of creating “communities of opportunity” that will allow all families to thrive—both during and after this pandemic.

Vaccinations are seen as the primary tool to prevent COVID-19 infections, but are there other things we should be doing to bring down transmission rates? In this episode, Dr. Caitlin Rivers and Dr. Crystal Watson from the Center for Health Security return to the podcast to talk with Dr. Josh Sharfstein about where we are, what still needs to be done, and when they’ll know that the pandemic is truly in the rearview mirror.

Drawing on personal experiences, Will Welch, the global editorial director of GQ, discussed COVID-19’s impact on addiction, sobriety and art with Danny Winder, director of the Vanderbilt Center for Addiction Research, and Erin Calipari, assistant professor of pharmacology, during an April 21 event.

ABC News’ Kayna Whitworth speaks with parents whose children are currently enrolled in early COVID-19 vaccine trials for children under 16 years old, and the researchers from Stanford University conducting the studies.

MIT alumni and friends from around the globe attended an online event that featured presentations from Institute leaders, faculty, and alumni about human health-related research.

In this episode of the Public Health on Call podcast, Dr. Josh Sharfstein talks with Hopkins researchers who break down three papers looking at reinfection. Dr. Sheree Schwartz, an epidemiologist, talks about a CDC paper on reinfections in a single Kentucky nursing home. Henri Garrison-Desany, a doctoral student in epidemiology, talks about two papers: a Lancet paper from Denmark and one in the Journal of Infection from Brazil.

James Crowe, MD, and members of his lab at Vanderbilt University Medical Center who have pioneered rapid development of monoclonal antibody treatments for life-threatening viral diseases including COVID-19, were featured April 11 on a CBS News 60 Minutes segment titled “The Last Pandemic.”

We’re in a strange “limbo” where vaccinations are on the rise, but so are hospitalizations. Epidemiologist Keri Althoff and mental health expert Elizabeth Stuart return to the podcast to talk with Stephanie Desmon about making safe decisions, why vaccinated people shouldn’t take off their masks just yet, and the need for flexibility as mixed messaging and lots of transitions may be the “new normal” for now.

In this video, BU public health experts discuss the future of the pandemic as vaccines ramp up while viral variants become more prevalent.

Vaccines are the biggest thing on everyone′s mind right now. Whether there is hesitancy or people scrambling to get their two doses, the question is how to get 80% of adults to get the shots? In this episode, we dissect people’s fears and connect with a community leader who is trying to educate people and also make sure everyone who wants a vaccine can get one. This episode is hosted by Phyllis Arthur and features a conversation with Dr. Reed Tuckson, founder of the Black Coalition Against COVID-19.

A new study by researchers in MIT’s Department of Mechanical Engineering suggests that coronaviruses may be vulnerable to ultrasound vibrations, within the frequencies used in medical diagnostic imaging.

Manoj Gandhi, Sr. Medical Director at Thermo Fisher Scientific, interviews Dr. Stephen Morse, professor of epidemiology at Columbia University. Manoj and Stephen address the doubts expressed by the general public regarding testing for COVID-19 and the need for continued testing even as vaccination rates continue to increase.

Steven J. Lawrence, MD, a professor of medicine in the Division of Infectious Diseases at Washington University in St. Louis, appeared on our first episode of “Show Me the Science.” One year later, he says we‘re getting close to returning to normal. But he also says we should think not so much about returning to the old normal as moving toward a new normal that may sometimes include screenings at work to make sure you‘re not sick, or perhaps smaller gatherings during cold and flu season.

Manoj Gandhi, Sr. Medical Director at Thermo Fisher Scientific, interviews Dr. Stephen Morse, professor of epidemiology at Columbia University. Manoj and Stephen address the doubts expressed by the general public regarding testing for COVID-19 and the need for continued testing even as vaccination rates continue to increase.

A film by the American Cancer Society Cancer Action Network (ACS CAN) features the stories of those disproportionally affected by the COVID-19 pandemic and stresses the importance of health insurance coverage for lower income individuals in Alabama. The film‘s urgent message continues to be at the forefront of conversations on public policy change that could significantly address the longstanding health and cancer disparities, exacerbated by the pandemic and provide lower income Alabamians access to comprehensive, affordable health insurance coverage.

This week marks one year since everything changed — our jobs, our lives, our spirit. Yet, as COVID-19 upended our days, the Washington University in St. Louis community — our faculty, students, staff and friends — refused to lose hope. This video shows how, as we as a community have carried on and continue to serve the greater good. We thank you, and are hopeful for better days ahead.

When the pandemic began, America’s biopharmaceutical companies immediately started to develop solutions to help diagnose, treat and prevent COVID-19 infection. While authorized vaccines provide hope that this pandemic may soon be over, the biopharmaceutical industry is preparing for the next public health emergency. PhRMA′s CEO, Stephen J. Ubl, will share lessons the biopharmaceutical has learned from COVID-19, what allowed the industry to respond so quickly and how we need to plan for future pandemics.

This episode discusses the use of wearables to detect infection and in particular, COVID-19. The presenters discuss the types of data wearables provide, including rest heart rate, skin temperature, etc. By assessing a patient’s health data, it is possible to determine when a person is becoming or is ill, even though they may be asymptomatic. This data is very useful, especially as it can be used to determine if a patient is infected with COVID-19, even before they know they are ill. If patients can be alerted to this, it may prevent them from infecting others. Studies being conducted at Stanford show the positive impacts of wearables on detecting illness in the population of people who track their health through wearables.

The diversity of our adaptive immune system is why people are reacting so differently to the novel coronavirus. No two people present the virus the exact same way to their immune systems. We‘ve evolved in this way as humans to ensure no virus can eradicate our species.

Many people who have had COVID-19 struggle for months with heart problems, shortness of breath, fatigue or loss of smell. In this episode, we hear about how Washington University School of Medicine physicians are working to help patients with lingering problems following COVID-19.

In this video, Washington University in St. Louis’ Cheri LeBlanc, MD, executive director of Habif Health and Wellness Center, and Steven Lawrence, MD, associate professor of medicine, share reasons why self-screening for COVID-19 is so important before visiting campus.

Discover how BD and its employees are mobilizing to develop novel diagnostics, help ensure critical delivery of patient care and support the discovery of treatments in response to COVID-19.

Experts explain why recruiting clinical trial participants from diverse backgrounds around the world—young, old, Black, brown, Indigenous and more—is critical to developing a potential COVID-19 vaccine, in this bonus clip from “The Road to a Vaccine.”

A doctor at UPenn is using her platform to raise awareness about inequities in health care and show the community the COVID-19 vaccine is safe.

By the end of the week, drug maker Johnson and Johnson is expected submit its COVID-19 vaccine to the FDA for emergency use authorization.

Johnson & Johnson Chief Scientific Officer Dr. Paul Stoffels, Harvard’s Dr. Dan Barouch and others discuss where we are in the fight against COVID-19 and learn what’s next for vaccine development. Plus, other news with Dr. Uché Blackstock.

On CNBC’s Mad Money With Jim Cramer, Thermo Fisher Scientific CEO Marc Casper explained his outlook for the necessity of coronavirus vaccines and therapies as the country continues to battle the pandemic.

In an interview with ABC News, Dr. Dan Barouch, a researcher who helped develop the Johnson & Johnson vaccine, breaks down the vaccine’s efficacy and how new variants complicated its development.

The pioneering work for the Moderna COVID-19 vaccine, which was granted emergency use authorization by the FDA, and the Pfizer vaccine began at the University of Pennsylvania more than a decade ago.

The coronavirus is changing much faster than scientists had expected, which could ultimately make it much harder to contain. But at Stanford University, a new effort is underway to help track these tricky variants in our community, which are already spreading in other parts of the world.

Listen to the year’s most popular episodes of the Breakthroughs podcast, featuring Northwestern Medicine experts discussing COVID-19 research.

Social and economic inequality has made minority communities more prone to contracting SARS-COV-2; the virus that causes COVID-19. One of those severely affected is the black community in the United States. On this episode of Science With a Twist, Fred Lowery, Senior Vice President and President of Life Sciences Solutions and Laboratory Products at Thermo Fisher Scientific, interviews Dr. James Hildreth, American immunologist and academic administrator. Fred and James discuss the “Just Project”‚ a multipronged effort to help address the coronavirus crisis, which has disproportionately impacted communities of color.

This episode of Show Me the Science contrasts the rapid development of effective vaccines with the lack of progress toward effective therapies. At present, all podcast episodes are highlighting research and patient care on the Washington University Medical Campus as our scientists and clinicians confront the COVID-19 pandemic.

Today on AmplifyNursing, we talk to Beth Toner. A Senior Communications Director at the Robert Wood Johnson Foundation, Beth is able to perfectly intersect her experience as a nurse and her previous career in journalism. A self-described nurse communicator, and storyteller, she supports the Foundation’s grantees, leadership, and nursing programs. Beth talks to us about the covid-19 pandemic, cringeworthy nursing stereotypes, and the power nurses have when they tell their stories.

Center Director, Jack P. Shonkoff, M.D. answers questions from PBS NewsHour’s William Brangham and viewers about how the COVID-19 pandemic and the long period of social distancing is affecting children and families.

Scientists expected there could be new versions of COVID-19, known as variants. But what scientists at the University of Pennsylvania want to know is: will the two vaccines work against them as well?

Research has found a specific kind of heart disease in people who have recovered from COVID-19. Myocarditis can cause serious complications, including in athletes. Dr. Haider Warraich, a cardiologist and researcher at Brigham and Women’s Hospital and Harvard Medical School, joins CBSNews AM to talk more about the illness.

NPR‘s Ari Shapiro talks with Dr. Steven Goodman of the Stanford School of Medicine about the ethical question of whether COVID-19 vaccine trials should be unblinded.

Microbiologist Susan Weiss, Ph.D. has been studying coronaviruses for four decades and is now co-director of Penn′s Center of research on coronavirus and other emerging pathogens. As for this new variant, she says there is still a lot to learn and as to whether it makes the virus spread faster, that hasn′t been scientifically proven yet.

A study of how 98 million Americans move around each day suggests that most infections occur at “superspreader” sites that put people in contact for long periods, and details how mobility patterns help drive higher infection rates among minority and low-income populations.

FOX Business’ Edward Lawrence provided details to on how Thermo Fisher Scientific is building cold-storage freezers to store the future coronavirus vaccine at various points of the supply chain at their site in Asheville, N.C.

Dr. Lloyd Minor, Stanford Medicine Dean, joins ‘Squawk on the Street’ to discuss the hospital’s distribution plan for Pfizer’s coronavirus vaccine and more.

Ron O’Brien speaks with Dr. Stephen Young, an expert in Microbiology, with a background in pathology, virology, and infectious diseases. They discuss what we should know during the potential viral storm produced by the collision of the seasonal flu and the COVID-19 pandemic.

Dr. Nancy Messonnier leads the Centers for Disease Control and Prevention’s work to safely vaccinate the country. Whether the question is who to vaccine first, how to restore trust, or how to administer two doses of a vaccine stored at -70 degrees to a nation of 328 million people, she’s got the answers.

President and CEO of Biotechnology Innovation Organization Dr. Michelle McMurry-Heath weighs in on America‘s News HQ.

Researchers from Northwestern University estimate food insecurity in America doubled in the first few months after the coronavirus arrived, and a recent CBS News poll shows more than one third of Americans are at least somewhat concerned they won‘t have enough money for groceries in the next year.

COVID threatens those whose immune systems can’t make enough neutralizing antibodies to fight off the viral invaders. But what if scientists could make super-potent antibodies in the lab and infuse them into newly infected patients? That’s exactly what the first FDA-authorized coronavirus antibody treatment has achieved. Its maker, Eli Lilly, has generated clinical evidence that their therapy can significantly reduce COVID hospitalization rates when taken early.

Americans suffering from Alzheimer’s disease and dementia are battling COVID-19 threats and the dangers of isolation.

As the world continues to cope with the COVID-19 pandemic, flu season has arrived once again. Watch Lisa Maragakis, senior director of infection prevention at the Johns Hopkins Health System and infectious diseases physician at The Johns Hopkins Hospital, and Aaron Milstone, associate hospital epidemiologist and pediatric infectious diseases specialist at Johns Hopkins Children’s Center, as they answer your questions about the flu and COVID-19.

How Boston University engineers built a 6,000-test-per-day system from scratch.

U.S. coronavirus cases have set a new single daily record, at more than 131,000. Dr. Lloyd Minor, Stanford University School of Medicine dean, joins ‘Power Lunch’ to discuss what tactical measures can be taken to help control the spread and the concerns surrounding a Covid-19 vaccine.

Lisa Ling speaks to Dr. Uché Blackstock about the racial inequities the pandemic has exposed, Dr. Alison Schwartz about battling a COVID-19 spike in Wisconsin and 14-year-old Anika Chebrolu about her prize-winning potential coronavirus therapy.

As the need grows for COVID-19 testing, so does a need to find a way to produce faster results. Engineers at Stanford think they’ve come up with an answer.

New video shows the first injection as Stanford doctors start phase three of the Johnson and Johnson COVID-19 vaccine trial. This phase three trial will be done at 180 sites around the world with 60,000 participants, 1,000 of them at Stanford. It’s a double-blind study, meaning some will get active vaccine while others will get a placebo. They’ll all be monitored.

View the full webinar from the October 13th, 2020 virtual event, featuring: Dr. Jamila Michener discussing the connection between racial disparities, COVID-19 and Medicaid; Dr. Alpa Patel sharing research from the American Cancer Society about the impact social determinants of health have on cancer patients; and Mike Perry sharing preliminary results from new messaging and polling research about race, health and the pandemic.

Overcrowded hospitals during the pandemic can pose treatment challenges for patients with other serious illnesses. As Kite Pharma CEO Christi Shaw says, “Cancer doesn’t stop in a crisis.” Neither do her company‘s employees, who go to extraordinary lengths to get personalized CAR-T treatments to patients around the world.

Vanderbilt University‘s latest analysis connecting a lack of mask requirements to larger increases in COVID-19 hospitalizations and surges in economic spending was featured on local WTVP News Nashville and MSN.com.

This episode of Show Me the Science highlights an effort led by scientists at Washington University in St. Louis to use computing power from around the world to identify vulnerabilities in the coronavirus.

Bloomberg School’s Ellen MacKenzie spoke with the nation’s top infectious diseases expert in the first installment of the university’s Health Policy Forum series. The series is jointly sponsored by the schools of Medicine, Nursing, and Public Health, and the Carey Business School. It is designed to bring together JHU faculty, students, and operational experts with policymakers to explore the development and implementation of health policy interventions.

This episode of Show Me the Science focuses on a saliva test developed by Washington University School of Medicine scientists to detect the virus that causes COVID-19.

In this bonus clip from Johnson & Johnson’s weekly live series, The Road to a Vaccine, we touch on the topic of why you should trust science now more than ever. Watch as health experts explain how focusing on science is crucial to ending the COVID-19 pandemic—and why the stakes in the U.S.

Nicholas Adams, research assistant professor of biomedical engineering, discusses what testing for the COVID-19 might look like as we enter cold and flu season.

In this episode of the Bloomberg Businessweek podcast, Dr. Megan Collins, Assistant Professor of the Johns Hopkins Berman Institute of Bioethics, discusses safely reopening schools amid the pandemic.

In this episode, Ron O’Brien speaks with Mary Kay Bates, Senior Cell Culture Scientist at Thermo Fisher Scientific. Mary gives us an inside look into the complex world of vaccine development and why developing one for COVID-19 has been so different.

This episode will provide up to date insights in the association between diabetes and COVID-19. Dr. Nicolas Cuttriss will address questions about COVID and diabetes, including; Is there an increased risk of getting COVID infection if a patient has diabetes? Is there an increased risk for mortality? Are patients more at risk for getting COVID simply because they have diabetes? Who is most at risk? The elderly? Pediatric patients? How do you manage COVID in patients with diabetes? How has the pandemic changed the discussion in terms of the social determinants of health? Is telemedicine effect in managing diabetes in patients who cannot come to the clinic? Listen in to find out the answers to these questions and more.

NPR`s Lulu Garcia-Navarro speaks to Harvard researcher Dr. Jose Figueroa about how COVID-19 disproportionately impacts Black and Latino communities, and how policy makers could address those issues.

Three hundred new workers at the Thermo Fisher factory in Lenexa are making shipping tubes they’ll use to send COVID tests to the labs.

As the fight to research and develop innovative treatments and vaccines advances, three biopharmaceutical scientists share what they have in common: combatting COVID-19.

This episode of Show Me the Science details new research from scientists at Washington University School of Medicine in St. Louis suggests that the immune systems of such patients can′t do enough to protect them from the virus. The researchers are proposing boosting the activity of immune cells to treat some patients with COVID-19.

In this video, The Brink goes behind the scenes at Boston University’s Kilachand Center for Integrated Life Sciences & Engineering to see how scientists are safely returning to the lab.

In this podcast produced by Northwestern’s Feinberg School of Medicine, a team of Northwestern scientists have come together from across disciplines to develop a COVID-19 antibody test designed for at-home use. Elizabeth McNally, MD, PhD, is part of the team working on this test to determine prior exposure to the virus.

In this video, watch BU graduate researcher Jessie Song 3D print prototypes of alternative nasopharyngeal swabs, which could help bridge the supply shortage caused by global demands for coronavirus testing.

Michelle Williams, Dean of Harvard’s T.H. Chan School of Public Health, joins CNBC’s “Squawk Box” for a closer look at how schools are grappling with how to safely reopen.

Johns Hopkins Assistant Professor of Emergency Medicine Lauren Sauer discusses understanding how antibody production works in the fight against Covid-19. She speaks with Bloomberg’s Francine Lacqua.

Dr. Scott Atlas, a former chief of neuroradiology at Stanford University Medical Center and a senior fellow at Stanford’s Hoover Institution joined the Daily Caller’s Stephanie Hamill to share his views on the reopening of schools in the fall amid the coronavirus pandemic.

University of Pennsylvania School of Nursing faculty member and LDI Senior Fellow Adriana Perez conducts research in two of the Philadelphia area’s largest Latino communities. She provides insights into how COVID-19 is impacting each.

Although COVID-19 doesn’t necessarily discriminate, some communities are far more susceptible to the disease. People who are black or African-American are more likely to contract the virus – and to die from it. In this podcast produced by Northwestern’s Feinberg School of Medicine, Clyde Yancy, MD, discusses reasons for these outcomes and the need to fully address health care disparities in America.

Hundreds of thousands of people are being tested for SARS-CoV-2 (COVID-19) around the world and the tests themselves are a crucial starting point in efforts to flatten the spread of the virus. This episode of Thermo Fisher Scientific’s Science with a Twist podcast talks with Senior Director of Genetic Sciences, Joshua Tratta who explains how tests are created, how they’re performed and how they’re analyzed.

While the coronavirus pandemic has changed many things around the world, it has not stopped child development. In this series of special episodes of The Brain Architects – a podcast from the Center on the Developing Child at Harvard University – we aim to share helpful resources and ideas in support of all those who are caring for children while dealing with the impacts of COVID-19.

Produced by the Biotechnology Innovation Organization and hosted by former Congressman Jim Greenwood, this is the only podcast at the intersection of biotechnology, politics, patients and the planet. We spotlight next-generation breakthroughs, the people they help, the global problems they solve and politicians with the power to fast-track a better future or mess it all up. Current episodes look at COVID-19 from a variety of different angles.

Listen to this special series of Stanford Engineering’s The Future of Everything podcast to learn how researchers from across the university are bringing their insights and knowledge to address the challenges of COVID-19.

As the Coronavirus continues to spread, doctors, scientists and health agencies are racing to contain the outbreak. In this episode of Thermo Fisher‘s Science with a Twist podcast, hear how they are using scientific technologies to detect, prevent and develop a vaccine for this respiratory syndrome.

Vanderbilt University faculty are sharing their expertise on a range of topics related to COVID-19. Subscribe to Vanderbilt’s “Ask an Expert” series on YouTube to get the latest updates.

TIME speaks with Christopher Gill, MD, an associate professor of global health at Boston University School of Public Health, about the ways the COVID-19 virus can spread human to human, whether the virus is airborne, and if transmission makes a difference indoors versus outdoors.

Johns Hopkins University Professor of Nursing Jason Farley explains the timeline for vaccine testing and the dangers of a second wave of coronavirus infections later in the year during cold and flu season. He speaks on “Bloomberg Surveillance.”

Hosted by prominent journalist Lisa Ling, Johnson & Johnson’s social-first show titled The Road to a Vaccine series features interviews with scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

Just as you are doing your part to fight the novel coronavirus, America’s Biopharmaceutical Companies are working around the clock to fight COVID-19. Click to watch video.

Stanford University’s Freeman Spogli Institute for International Studies (FSI) senior fellows Karen Eggleston and David Relman join host Michael McFaul to discuss what you should know about COVID-19 and its impact on the world.

With the number of COVID-19 cases climbing daily, some doctors and researchers are looking to bring back a very old therapy: the transfusion of antibodies from the plasma of recovered COVID-19 patients into patients battling COVID-19 infection.

In this episode, Jeffrey P. Henderson, MD, PhD, an associate professor in the Division of Infectious Diseases at Washington University in St. Louis, discusses the effort to test plasma as a way to treat very ill patients.

Amplify Nursing is a Penn Nursing podcast supported by the Pinola Fund for Innovation in Nursing. Episodes highlight the breadth and depth of nursing influence on society by amplifying nurses who are pushing boundaries and breaking down barriers to build a new paradigm.

Experts from the Johns Hopkins Bloomberg School of Public Health offer science and evidence-based insights on the public health news of the day. The current focus is the novel coronavirus spreading around the world.

The outbreak of a novel coronavirus in China is making headlines around the world. In this podcast produced by Northwestern’s Feinberg School of Medicine, microbiologist Karla Satchell, PhD, is leading an effort to investigate the structure biology of the components of the virus to ultimately understand how to stop it from replicating in human cells through a medication or vaccine.

What does COVID-19 mean for cancer patients and caregivers? How can they lower their risk of infection? How can everyone help reduce risk for this vulnerable population? What should cancer patients do if they are undergoing treatment?

American Cancer Society-funded scientists discuss the most critical questions in cancer research and recent challenges posed by COVID-19 pandemic.

As COVID-19 continues to push unprecedented challenges on medical communities, one of the most pressing threats for hospital staff across the country is a dwindling supply of ventilators.

In this video, an interdisciplinary team of Vanderbilt University and Vanderbilt University Medical Center faculty show how to use common materials to build a ventilator.